| Literature DB >> 27529747 |
Cristina Ballesteros1, Lucienne Tritten1, Maeghan O'Neill1, Erica Burkman2,3, Weam I Zaky3,4, Jianguo Xia1, Andrew Moorhead2,3, Steven A Williams3, Timothy G Geary1.
Abstract
BACKGROUND: Lymphatic filariasis and onchocerciasis are disabling and disfiguring neglected tropical diseases of major importance in developing countries. Ivermectin is the drug of choice for mass drug administration programs for the control of onchocerciasis and lymphatic filariasis in areas where the diseases are co-endemic. Although ivermectin paralyzes somatic and pharyngeal muscles in many nematodes, these actions are poorly characterized in adult filariae. We hypothesize that paralysis of pharyngeal pumping by ivermectin in filariae could result in deprivation of essential nutrients, especially iron, inducing a wide range of responses evidenced by altered gene expression, changes in metabolic pathways, and altered developmental states in embryos. Previous studies have shown that ivermectin treatment significantly reduces microfilariae release from females within four days of exposure in vivo, while not markedly affecting adult worms. However, the mechanisms responsible for reduced production of microfilariae are poorly understood. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27529747 PMCID: PMC4986938 DOI: 10.1371/journal.pntd.0004929
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Study design.
At each time point, two or three groups of 10 worms were washed, flash-frozen (represented by lightning bolt) and used for RNA extraction. IVM: ivermectin.
Picard alignment summary metrics.
Summary of the sequencing and mapping of the data to the B. malayi transcriptome.
| Time point | Concentration | Total # Transcripts | Ave Total # Reads | Ave Total # Reads Mapped | Ave Total # High Quality Reads Mapped | % High Quality Reads Mapped | |
|---|---|---|---|---|---|---|---|
| IVM (100 nM) | 10691 | 3537601 | 3537500 | 2990362 | 84.53 | ||
| Control | 10511 | 2765626 | 2765551 | 2364245 | 85.49 | ||
| IVM (100 nM) | 10086 | 2513891 | 2513834 | 2145661 | 85.35 | ||
| Control | 10214 | 2957918 | 2957831 | 2519799 | 85.19 | ||
| IVM (100 nM) | 10705 | 3875640 | 3874592 | 3380930 | 87.24 | ||
| Control | 10428 | 3081545 | 3081499 | 2683543 | 87.09 | ||
| IVM (300 nM) | 10087 | 2091222 | 2091198 | 1710598 | 81.80 | ||
| IVM (1 μM) | 10177 | 2212133 | 2212085 | 1757015 | 79.43 | ||
| Control | 10328 | 2808908 | 2808880 | 2325764 | 82.80 | ||
| IVM (300 nM) | 9959 | 1799180 | 1799161 | 1456538 | 80.96 | ||
| IVM (1 μM) | 9837 | 1798183 | 1798159 | 1426230 | 79.32 | ||
| Control | 10250 | 2464701 | 2464671 | 2017612 | 81.86 |
Numbers of differentially expressed genes over time after IVM exposure in culture.
| 100 nM IVM | 300 nM IVM | 1 μM IVM | |||||
|---|---|---|---|---|---|---|---|
| 24 h | 48 h | 72 h | 48 h | 5 d | 48 h | 5 d | |
| Total DE genes | 34 | 421 | 15 | 132 | 68 | 147 | 271 |
| Total DE genes up-regulated | 21 | 141 | 2 | 14 | 24 | 136 | 74 |
| Total DE genes down-regulated | 13 | 280 | 13 | 118 | 44 | 11 | 197 |
| Sequences with GO terms | 7 | 178 | 9 | 86 | 29 | 49 | 160 |
| Sequences with | 7 | 257 | 9 | 92 | 37 | 64 | 186 |
*GO terms were provided by Nematode.net V.4 [33]. IVM: ivermectin; DE: differentially expressed
Gene Ontology enrichment analysis of top 15 biological processes at 100 nM IVM exposure for 48 h.
| Gene Ontology Term | GO Identity | Observed | Expected | Reference | Ratio of Enrichment | FDR value |
|---|---|---|---|---|---|---|
| growth | GO :0040007 | 85 | 45.16 | 2498 | 1.88 | 2.03E-08 |
| locomotion | GO :0040011 | 63 | 30.10 | 1665 | 2.09 | 2.99E-07 |
| embryo development | GO :0009790 | 91 | 55.49 | 3069 | 1.64 | 1.07E-06 |
| embryo development ending in birth or egg hatching | GO :0009792 | 89 | 54.10 | 2992 | 1.65 | 1.07E-06 |
| nematode larval development | GO :0002119 | 72 | 39.00 | 2157 | 1.85 | 1.07E-06 |
| larval development | GO :0002164 | 72 | 39.03 | 2159 | 1.84 | 1.07E-06 |
| post-embryonic development | GO :0009791 | 72 | 39.31 | 2174 | 1.83 | 1.07E-06 |
| establishment of localization | GO :0051234 | 65 | 33.63 | 1860 | 1.93 | 1.07E-06 |
| transport | GO :0006810 | 63 | 32.33 | 1788 | 1.95 | 1.21E-06 |
| regulation of growth | GO :0040008 | 61 | 31.24 | 1728 | 1.95 | 1.96E-06 |
| positive regulation of growth | GO :0045927 | 59 | 29.90 | 1654 | 1.97 | 2.32E-06 |
| positive regulation of growth rate | GO :0040010 | 54 | 26.27 | 1453 | 2.06 | 2.38E-06 |
| regulation of growth rate | GO :0040009 | 54 | 26.31 | 1455 | 2.05 | 2.38E-06 |
| cellular localization | GO :0051641 | 26 | 7.85 | 434 | 3.31 | 2.38E-06 |
| reproduction | GO :0000003 | 80 | 48.00 | 2655 | 1.67 | 3.76E-06 |
*Analysis performed using Web-Based Gene Set Analysis Toolkit (WebGestalt).
**Statistical method: Hypergeometric; p-value adjusted using the Benjamini-Hochberg multiple test adjustment.
Fig 2Top RNAi phenotypes enriched in reproductive processes after 48 h exposure to 100 nM IVM.
The listed enriched phenotypes obtained were based on Gene Ontology analysis of C. elegans orthologs of DE genes. These phenotypes were significantly overrepresented compared with their overall abundance in the C. elegans RNAi phenotype dataset in Wormbase. Statistical method: Hypergeometric; p-value adjusted using the Benjamini-Hochberg multiple test adjustment (FDR<0.05).